NAL
Click for more information
0.00% 0.6¢ norwood abbey limited

bounce, takeover or down from here?

  1. sarge17
    3,294 Posts.
    lightbulb Created with Sketch. 776
    clock Created with Sketch.
    11/02/05
    17:45
    Post #: 789271
    I've been buying NAL from 62c to 57c today. Would any current holders or previous holders of the stock care to comment where to from here for the share price. The company appears fundamentally sound with their holding in Norwood Immunology, cash and expected 2nd half revenue from Eyecare. Additionally the eminent physicians/directors and US hospitals involved in the US trials are worlds best.

    I regret if this sounds like a ramp but I would imagine that Norwood Abbey at these prices or lower could prove a tempting target for a couple of Australian or any one of a number overseas Bio/Pharma companies.

    Anyone care to comment?
    NAL Price at posting: 0.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.